Twynstar showing robust sales in May

Boehringer Ingelheim’s antihypertensive Twynstar has expand a bigger market share at the brisk pace as its sales in May stood at 4.8 billion won, according to Yakup.com, a pharmaceutical information provider. The drug posted 33 billion won in sales last year.

Market observers said the robust sales of Twynstar have been chiefly attributable to the strong marketing campaign of Yuhan Corp., a c...